Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Women's Health Homepage

Hologic launches Unifi Analytics to curb mammo downtime Predicting tube failures before they happen and setting performance benchmarks

Three decades of data clearly show mammography saves lives Breast cancer mortality statistics support benefits of mammo and early detection

Sarah Silverman calls out radiologist after bad breast screening experience 'Wear f**king GLOVES,' she wrote on Instagram, 'this isn’t a date'

Self-compression for breast cancer screening yields clinical advantages French study finds benefits in giving patients greater control

Mammo prior to breast reduction surgery may do more harm than good Researchers point to unnecessary follow-up, financial risk

New breast imaging modality may reduce unnecessary biopsies by up to 45 percent Combining ultrasound and near-infrared imaging

Putting the patient at the center of breast care Insights from Agnes Berzsenyi, president and CEO of GE Healthcare Women’s Health

Transforming the breast cancer screening experience with ready access to clinical data Breaking down barriers for better clinical outcomes

MobileODT deploys EVA System in first large-scale AI pilot for cervical cancer screenings Partnered with Apollo Hospitals and Genworks

Mammography screenings higher in coastal cities, says study Examined disparities in screening mammography utilization at city level

Dr. Nila H. Alsheik

Beyond detection: How DBT utilization rates impact facility benchmarks

From the November 2018 issue of DOTmed HealthCare Business News magazine

By Dr. Nila H. Alsheik

Digital breast tomosynthesis (DBT), or 3D screening mammography, has again been solidified as the gold standard of care for breast screening according to a recent study published in Academic Radiology, and more and more facilities are offering this technology.

Despite this trend, however, utilization rates at many facilities nationwide still remain suboptimal, with only partial conversion rates to DBT. For facilities aiming for the highest patient outcomes, including reduced recall rates and optimized cancer detection rates, conversion rates over 75 percent to DBT screening confer the highest benefits.
Story Continues Below Advertisement

GE Healthcare ultrasound probe solutions to help protect your investment

GE Healthcare helps reduce the downtime of ultrasounds with online access to probe and accessory purchasing, probe-failure diagnoses, fast repairs and replacements, probe care and handling tips, and reliable service options.

Standardization of clinical protocols in the screening and diagnostic setting is critically important in the era of DBT. DBT confers lower recall rates and higher cancer detection rates, regardless of breast density. The data, therefore, supports uniform screening DBT utilization in all patients, and not just in those who have heterogeneously or extremely dense breast tissue. Conversely, patient care and facility performance are not optimized in hybrid screening environments where there is more than 25 percent 2D screening utilization.

To compare outcomes associated with breast cancer screening with 2D mammography alone versus in combination with DBT, researchers analyzed patient-level demographics, calculated risk levels, and clinical outcomes of more than 190,000 DBT exams and more than 130,000 DM/2D screening examinations over a two-year period at 39 imaging facilities across two healthcare systems. The study, which utilized multiple benchmarks including cancer and invasive cancer detection rates, specificity, tumor grade, size and stage of tumor at diagnosis and nodal status, demonstrated that DBT conferred a 22 percent higher cancer detection rate, as well as a sustained decrease in recall rates across the entire cohort, compared to 2D alone.

The implications of the study are far-reaching, as recalls due to false positives have been shown to create anxiety and reduce patient compliance with future screening mammography. As such, heightened sensitivity and specificity in mammography not only affects the rate of cancer detection, but potentially reduces morbidity and cost arising from unnecessary downstream procedures and imaging. In addition to being more effective than 2D alone, DBT recall rates were also lower at sites that predominantly performed DBT screening (8.02 percent), compared to facilities that perform a mix of 2D alone and DBT screening (10.43 percent).
  Pages: 1 - 2 >>

Women's Health Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.